Phibro Animal Health (PAHC) Sets New 52-Week High and Low at $44.35

Phibro Animal Health (NASDAQ:PAHC)’s share price hit a new 52-week high and low on Wednesday . The stock traded as low as $44.35 and last traded at $43.75, with a volume of 60632 shares changing hands. The stock had previously closed at $44.00.

PAHC has been the topic of several research reports. ValuEngine upgraded shares of Phibro Animal Health from a “hold” rating to a “buy” rating in a report on Wednesday, February 28th. Zacks Investment Research upgraded shares of Phibro Animal Health from a “hold” rating to a “buy” rating and set a $41.00 price objective on the stock in a report on Thursday, February 8th. BidaskClub upgraded shares of Phibro Animal Health from a “sell” rating to a “hold” rating in a report on Wednesday. Credit Suisse Group upped their price objective on shares of Phibro Animal Health from $37.00 to $39.00 and gave the company a “neutral” rating in a report on Tuesday, February 6th. Finally, Morgan Stanley boosted their target price on shares of Phibro Animal Health from $30.00 to $36.00 and gave the stock an “underweight” rating in a research report on Wednesday, February 7th. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the company. The company presently has an average rating of “Hold” and a consensus target price of $38.20.

How to Become a New Pot Stock Millionaire

The company has a current ratio of 3.12, a quick ratio of 1.75 and a debt-to-equity ratio of 1.82. The stock has a market capitalization of $1,712.14, a PE ratio of 29.14, a PEG ratio of 3.02 and a beta of 0.93.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings data on Monday, February 5th. The company reported $0.44 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.38 by $0.06. Phibro Animal Health had a net margin of 7.90% and a return on equity of 40.49%. The business had revenue of $205.90 million during the quarter, compared to the consensus estimate of $194.90 million. During the same period in the prior year, the firm posted $0.39 EPS. The firm’s quarterly revenue was up 7.5% compared to the same quarter last year. equities analysts predict that Phibro Animal Health will post 1.69 EPS for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, March 28th. Shareholders of record on Wednesday, March 7th were given a $0.10 dividend. This represents a $0.40 dividend on an annualized basis and a yield of 0.91%. The ex-dividend date was Tuesday, March 6th. Phibro Animal Health’s payout ratio is 26.49%.

In other news, CEO Jack Bendheim sold 2,802 shares of the stock in a transaction that occurred on Thursday, February 22nd. The shares were sold at an average price of $38.01, for a total transaction of $106,504.02. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, major shareholder Bfi Co., Llc sold 12,000 shares of the stock in a transaction that occurred on Wednesday, March 14th. The shares were sold at an average price of $40.12, for a total transaction of $481,440.00. Following the transaction, the insider now directly owns 24,000 shares of the company’s stock, valued at $962,880. The disclosure for this sale can be found here. Insiders sold a total of 276,056 shares of company stock valued at $10,495,260 over the last ninety days. 51.88% of the stock is currently owned by insiders.

Several institutional investors have recently added to or reduced their stakes in PAHC. Russell Investments Group Ltd. lifted its stake in shares of Phibro Animal Health by 7.6% during the 3rd quarter. Russell Investments Group Ltd. now owns 44,173 shares of the company’s stock valued at $1,636,000 after buying an additional 3,105 shares in the last quarter. Macquarie Group Ltd. purchased a new stake in shares of Phibro Animal Health during the 3rd quarter valued at approximately $289,000. Dimensional Fund Advisors LP lifted its stake in shares of Phibro Animal Health by 11.8% during the 3rd quarter. Dimensional Fund Advisors LP now owns 465,297 shares of the company’s stock valued at $17,239,000 after buying an additional 49,296 shares in the last quarter. Allianz Asset Management GmbH lifted its stake in shares of Phibro Animal Health by 2.3% during the 3rd quarter. Allianz Asset Management GmbH now owns 108,930 shares of the company’s stock valued at $4,036,000 after buying an additional 2,465 shares in the last quarter. Finally, California Public Employees Retirement System lifted its stake in shares of Phibro Animal Health by 9.5% during the 3rd quarter. California Public Employees Retirement System now owns 44,994 shares of the company’s stock valued at $1,667,000 after buying an additional 3,894 shares in the last quarter. 48.08% of the stock is owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION NOTICE: This piece of content was first reported by Week Herald and is the sole property of of Week Herald. If you are viewing this piece of content on another domain, it was illegally stolen and reposted in violation of United States and international copyright & trademark laws. The legal version of this piece of content can be read at https://weekherald.com/2018/04/18/phibro-animal-health-pahc-sets-new-52-week-high-and-low-at-44-35.html.

About Phibro Animal Health

Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture.

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply